Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda B Spurdle

Showing results (11-20 of 397) with videos related to

Pageof 40
Sort By:
Journal of Personalized Medicine|January 8, 2015
Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australiaYen Y Tan, Amanda B Spurdle, Andreas Obermair
Cancers|September 29, 2019
Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk LociTracy A O'Mara, Amanda B Spurdle, Dylan M Glubb, et al.
European Journal of Human Genetics : EJHG|March 13, 2026
Survey of diagnostic laboratories highlights need for improved standards in somatic genomic testing and reportingGrace Pendlebury, Emma Tudini, James Andrews, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitorsTracy A O'Mara, Judith A Clements, Amanda B Spurdle
The New England Journal of Medicine|August 24, 2017
More on Co-Occurrence of COMT and BRCA1/2 Variants in a PopulationAmanda B Spurdle, David E Goldgar, Douglas F Easton
Biomed Research International|August 19, 2014
Biomarkers in women's cancers, gynecology, and obstetricsPeter A Fasching, Gottfried E Konecny, Amanda B Spurdle
Journal of Medical Genetics|January 5, 2023
Reporting clinically relevant genetic variants unrelated to genomic test requests: a survey of Australian clinical laboratory policies and practicesEmma Tudini, Matilda A Haas, Tessa Mattiske, et al.
Breast Cancer Research and Treatment|March 22, 2012
Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumoursLogan C Walker, Lutz Krause, , et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 29, 2017
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testingAmanda B Spurdle, Michael A Bowman, Jannah Shamsani, et al.
Frontiers in Pharmacology|May 11, 2017
The Association of <i>CYP19A1</i> Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can <i>CYP19A1</i> Variants Be Used to Predict Treatment Efficacy?Dylan M Glubb, Tracy A O'Mara, Jannah Shamsani, et al.
Pageof 40

Showing results (11-20 of 397) with videos related to

Sort By:
Pageof 40
Journal of Personalized Medicine|January 8, 2015
Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australiaYen Y Tan, Amanda B Spurdle, Andreas Obermair
Cancers|September 29, 2019
Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk LociTracy A O'Mara, Amanda B Spurdle, Dylan M Glubb, et al.
European Journal of Human Genetics : EJHG|March 13, 2026
Survey of diagnostic laboratories highlights need for improved standards in somatic genomic testing and reportingGrace Pendlebury, Emma Tudini, James Andrews, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitorsTracy A O'Mara, Judith A Clements, Amanda B Spurdle
The New England Journal of Medicine|August 24, 2017
More on Co-Occurrence of COMT and BRCA1/2 Variants in a PopulationAmanda B Spurdle, David E Goldgar, Douglas F Easton
Biomed Research International|August 19, 2014
Biomarkers in women's cancers, gynecology, and obstetricsPeter A Fasching, Gottfried E Konecny, Amanda B Spurdle
Journal of Medical Genetics|January 5, 2023
Reporting clinically relevant genetic variants unrelated to genomic test requests: a survey of Australian clinical laboratory policies and practicesEmma Tudini, Matilda A Haas, Tessa Mattiske, et al.
Breast Cancer Research and Treatment|March 22, 2012
Germline copy number variants are not associated with globally acquired copy number changes in familial breast tumoursLogan C Walker, Lutz Krause, , et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 29, 2017
Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testingAmanda B Spurdle, Michael A Bowman, Jannah Shamsani, et al.
Frontiers in Pharmacology|May 11, 2017
The Association of <i>CYP19A1</i> Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can <i>CYP19A1</i> Variants Be Used to Predict Treatment Efficacy?Dylan M Glubb, Tracy A O'Mara, Jannah Shamsani, et al.
Pageof 40